224 related articles for article (PubMed ID: 12856664)
1. Pharmacy benefit management: the right Rx?
Etheredge L
Res Agenda Brief; 1995 Apr; (1):1-11. PubMed ID: 12856664
[No Abstract] [Full Text] [Related]
2. Specialty pharmacy management adjusts to new financial realities.
Reinke T
Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
[No Abstract] [Full Text] [Related]
3. The evolving pharmacy benefit market.
Navarro RP
Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345
[TBL] [Abstract][Full Text] [Related]
4. Need for integrated data in pharmacy benefits.
Martens G; Clor GE
J Health Care Benefits; 1993; 3(1):57-60. PubMed ID: 10130352
[No Abstract] [Full Text] [Related]
5. Risk contractors take aim at skyrocketing drug costs.
Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047
[No Abstract] [Full Text] [Related]
6. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
Alexander W
Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
[No Abstract] [Full Text] [Related]
7. The managed care prescription benefit. Challenged by shifting care and shifting costs.
Bender J
AAPPO J; 1991; 1(4):11-8. PubMed ID: 10149632
[No Abstract] [Full Text] [Related]
8. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
[No Abstract] [Full Text] [Related]
9. Forecasting the future.
Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
[No Abstract] [Full Text] [Related]
10. Pharmacy carve-out offers cost control, computer modeling.
Capitation Manag Rep; 2002 Jul; 9(7):103-8, 97. PubMed ID: 12164058
[TBL] [Abstract][Full Text] [Related]
11. Shifting gears.
Tweed V
Bus Health; 1994 May; 12(5):28-9, 32, 34 passim. PubMed ID: 10134334
[No Abstract] [Full Text] [Related]
12. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
Berger J
Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
14. The evolving role of pharmacy benefits management firms in a managed care environment.
O'Leary JS
Benefits Q; 1995; 11(3):24-33. PubMed ID: 10151118
[TBL] [Abstract][Full Text] [Related]
15. Pharmacy discount card programs: catching up with the health markets.
Edwards D
Empl Benefits J; 2002 Sep; 27(3):42-3. PubMed ID: 12219563
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical risk sharing may cut losses, but is unlikely to produce gain.
Exec Solut Healthc Manag; 1998 Oct; 1(8):8-10. PubMed ID: 10186111
[No Abstract] [Full Text] [Related]
17. Cap for injectables not for the faint of heart.
Capitation Rates Data; 2003 Jul; 8(7):79-81. PubMed ID: 12908211
[No Abstract] [Full Text] [Related]
18. Tier 4 drugs and the fraying of the social compact.
Lee TH; Emanuel EJ
N Engl J Med; 2008 Jul; 359(4):333-5. PubMed ID: 18650510
[No Abstract] [Full Text] [Related]
19. New CA law protects capitated providers against rising specialty pharmacy costs.
Capitation Manag Rep; 2003 Jul; 10(7):102-3. PubMed ID: 12899093
[No Abstract] [Full Text] [Related]
20. Unraveling the ramifications of recent pharmaceutical industry acquisitions by looking at the past, present and future of PBMs (pharmacy benefit management firms).
Herzfeld JD
Empl Benefits J; 1995 Mar; 20(1):20-3, 30. PubMed ID: 10142515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
